XBiotech Inc.
XBIT
$2.92
-$0.06-2.01%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -49.55% | 87.84% | 18.39% | -20.14% | -0.50% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -57.66% | 24.85% | 1.87% | -7.23% | 12.88% |
| Operating Income | 57.66% | -24.85% | -1.87% | 7.23% | -12.88% |
| Income Before Tax | 86.74% | -8.80% | -122.83% | 29.05% | -50.28% |
| Income Tax Expenses | 212.00% | 16.00% | 58.59% | -97.08% | -135.21% |
| Earnings from Continuing Operations | 86.50% | -8.82% | -126.71% | 31.90% | -48.78% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 86.50% | -8.82% | -126.71% | 31.90% | -48.78% |
| EBIT | 57.66% | -24.85% | -1.87% | 7.23% | -12.88% |
| EBITDA | 59.42% | -25.78% | -1.91% | 7.70% | -13.32% |
| EPS Basic | 86.51% | -8.68% | -126.46% | 31.96% | -48.68% |
| Normalized Basic EPS | 86.76% | -8.64% | -122.63% | 29.12% | -50.22% |
| EPS Diluted | 86.51% | -8.68% | -121.80% | 31.96% | -47.24% |
| Normalized Diluted EPS | 86.76% | -8.64% | -122.63% | 29.12% | -50.22% |
| Average Basic Shares Outstanding | 0.10% | 0.14% | 0.08% | 0.12% | 0.06% |
| Average Diluted Shares Outstanding | 0.10% | 0.14% | 0.08% | 0.12% | 0.06% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |